About Glyphic Biotechnologies
Glyphic Biotechnologies is a private company based in New York, New York, incorporated in 2021 in Delaware. It has reported $33,179,812 raised in one offering on Form D since February 2024. Its chief executive is Joshua Yang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 7, 2024 | Feb 16, 2024 | $33,179,812of $52.9M target | 37 | $896K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Glyphic Biotechnologies's Form D filed Feb 16, 2024.
JY
Joshua Yang
Chief Executive Officer and director
CA
Craig Asher
Director
JY
Jimmy Yun
Director
DE
Daniel Estandian
Executive officer and director